Coffee induces expression of glucuronosyl transferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach

Gastroenterology

Volumn 139, Issue 5, 2010, Pages

  Kalthoff, Sandra ^a   Ehmer, Ursula ^a   Freiberg, Nicole ^a   Manns, Michael P ^a   Strassburg, Christian P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Coffee; Glucuronidation; Liver Cancer

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CAFESTOL; CAFFEINE; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A10; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A8; GLUCURONOSYLTRANSFERASE 1A9; GLYCOSYLTRANSFERASE; KAHWEOL; METAL; METHYLXANTHINE DERIVATIVE; PARAXANTHINE; SMALL INTERFERING RNA; THEOBROMINE; THEOPHYLLINE; TRANSCRIPTION FACTOR NRF2; UDP GLUCURONOSYLTRANSFERASE 1A; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CACAO; CELL CULTURE; CELL PROTECTION; CELL STRAIN CACO 2; CELL STRAIN HEPG2; COFFEE; CONTROLLED STUDY; FEMALE; GLUCURONIDATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LIVER; MALE; MOUSE; MUTAGENESIS; NONHUMAN; PAPER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE; STOMACH; TEA; TRANSGENIC ANIMAL; XENOBIOTIC METABOLISM;

EID: 77958093867     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.06.048     Document Type: Article

References (41)

1. I.S. Cadden, N. Partovi, and E.M. Yoshida Review article: possible beneficial effects of coffee on liver disease and function Aliment Pharmacol Ther 26 2007 1 8
2. A. Crozier, I.B. Jaganath, and M.N. Clifford Dietary phenolics: chemistry, bioavailability and effects on health Nat Prod Rep 26 2009 1001 1043
3. A. Nehlig, and G. Debry Potential genotoxic, mutagenic and antimutagenic effects of coffee: a review Mutat Res 317 1994 145 162
4. E. Arnesen, N.E. Huseby, and T. Brenn The Tromso Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population Scand J Clin Lab Invest 46 1986 63 70
5. K. Tanaka, S. Tokunaga, and S. Kono Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers Int J Epidemiol 27 1998 438 443
6. C.E. Ruhl, and J.E. Everhart Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States Gastroenterology 128 2005 24 32
7. S.C. Larsson, and A. Wolk Coffee consumption and risk of liver cancer: a meta-analysis Gastroenterology 132 2007 1740 1745 (Pubitemid 46677953)
8. A.A. Modi, J.J. Feld, and Y. Park Increased caffeine consumption is associated with reduced hepatic fibrosis Hepatology 51 2009 201 209
9. A.L. Klatsky, C. Morton, and N. Udaltsova Coffee, cirrhosis, and transaminase enzymes Arch Intern Med 166 2006 1190 1195
10. N.D. Freedman, J.E. Everhart, and K.L. Lindsay Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C Hepatology 50 2009 1360 1369
11. G.W. Ross, R.D. Abbott, and H. Petrovitch Association of coffee and caffeine intake with the risk of Parkinson disease JAMA 283 2000 2674 2679
12. E. Salazar-Martinez, W.C. Willett, and A. Ascherio Coffee consumption and risk for type 2 diabetes mellitus Ann Intern Med 140 2004 1 8
13. Y. Je, W. Liu, and E. Giovannucci Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies Int J Cancer 124 2009 1662 1668
14. O.A. Gressner Less Smad2 is good for you! A scientific update on coffee's liver benefits Hepatology 50 2009 970 978
15. G. Corrao, A. Zambon, and V. Bagnardi Coffee, caffeine, and the risk of liver cirrhosis Ann Epidemiol 11 2001 458 465
16. M. Inoue, I. Yoshimi, and T. Sobue Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan J Natl Cancer Inst 97 2005 293 300
17. C. Cavin, C. Bezencon, and G. Guignard Coffee diterpenes prevent benzo[a]pyrene genotoxicity in rat and human culture systems Biochem Biophys Res Commun 306 2003 488 495
18. C. Cavin, M. Marin-Kuan, and S. Langouet Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver Food Chem Toxicol 46 2008 1239 1248
19. C.P. Strassburg, S. Kalthoff, and U. Ehmer Variability and function of family 1 uridine-5′-diphosphate glucuronosyltransferases (UGT1A) Crit Rev Clin Lab Sci 45 2008 485 530
20. S.A. Nowell, J.S. Massengill, and S. Williams Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5- b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved Carcinogenesis 20 1999 1107 1114
21. M.F. Yueh, N. Nguyen, and M. Famourzadeh The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines Carcinogenesis 22 2001 943 950
22. D.S. Vienneau, U. DeBoni, and P.G. Wells Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase- deficient cultured rat skin fibroblasts Cancer Res 55 1995 1045 1051
23. Y. Wang, N. Kato, and Y. Hoshida UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in japanese patients with hepatitis C virus infection Clin Cancer Res 10 2004 2441 2446
24. E.M. Van Der Logt, S.M. Bergevoet, and H.M. Roelofs Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk Carcinogenesis 25 2004 2407 2415
25. S.Y. Kong, C.S. Ki, and B.C. Yoo UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers Cancer Sci 99 2008 340 344
26. M. Kot, and W.A. Daniel Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat Pharmacol Rep 60 2008 789 797
27. T.J. Erichsen, U. Ehmer, and S. Kalthoff Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene Toxicol Appl Pharmacol 230 2008 252 260
28. T.O. Lankisch, T.C. Gillman, and T.J. Erichsen Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene Arch Toxicol 82 2008 573 582
29. T.O. Lankisch, A. Vogel, and S. Eilermann Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene Mol Pharmacol 67 2005 1732 1739
30. C.P. Strassburg, M.P. Manns, and R.H. Tukey Expression of the UDP-glucuronosyltransferase 1A locus in human colon Identification and characterization of the novel extrahepatic UGT1A8 J Biol Chem 273 1998 8719 8726
31. S. Chen, D. Beaton, and N. Nguyen Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus J Biol Chem 280 2005 37547 37557
32. R.J. Turesky, J. Richoz, and A. Constable The effects of coffee on enzymes involved in metabolism of the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine in rats Chem Biol Interact 145 2003 251 265
33. S. Kalthoff, U. Ehmer, and N. Freiberg Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10 J Biol Chem 285 2010 5993 6002
34. R.H. Tukey, and C.P. Strassburg Human UDP-glucuronosyltransferases: metabolism, expression, and disease Annu Rev Pharmacol Toxicol 40 2000 581 616
35. S. Okamura, K. Suzuki, and M. Yanase The effects of coffee on conjugation reactions in human colon carcinoma cells Biol Pharm Bull 28 2005 271 274
36. O.A. Gressner, B. Lahme, and K. Rehbein Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways J Hepatol 49 2008 758 767
37. C. Cavin, D. Holzhaeuser, and G. Scharf Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity Food Chem Toxicol 40 2002 1155 1163
38. H. Steinkellner, C. Hoelzl, and M. Uhl Coffee consumption induces GSTP in plasma and protects lymphocytes against (+/-)-anti-benzo[a]pyrene-7,8- dihydrodiol-9,10-epoxide induced DNA-damage: results of controlled human intervention trials Mutat Res 591 2005 264 275
39. K.J. Lee, J.H. Choi, and H.G. Jeong Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice Food Chem Toxicol 45 2007 2118 2125
40. L.G. Higgins, C. Cavin, and K. Itoh Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2 Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein Toxicol Appl Pharmacol 226 2008 328 337
41. C.P. Strassburg Pharmacogenetics of Gilbert's syndrome Pharmacogenomics 9 2008 903 915